MSTN and cancer: Several studies have demonstrated the therapeutic potential of Mstn inhibition under muscle wasting conditions as cancer [74,75]; consequently, the identification of Mstn as a putative target of miR-27b has potential therapeutic and biological implications in muscle wasting conditions.